Who Supplies Lenvatinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Lenvatinib exports, with 127+ registered manufacturers shipping to buyers across 74+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 35.0% (export value: $746.3K). Close behind, SANDOZ PRIVATE LIMITED (12.8%, $272.8K). PROSPERA LIFE SCIENCES PRIVATE LIMITED (4.8%, $101.9K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Lenvatinib? Top Manufacturers & Their Buyers
Flow of Lenvatinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Lenvatinib Supplier Network — Key Market Intelligence
The Lenvatinib export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 35.0% share, shipping $746.3K worth of product across 5 shipments. The second-largest exporter, SANDOZ PRIVATE LIMITED, contributes $272.8K (12.8%) to the overall market. Combined, the top two suppliers alone account for 47.8% of all Lenvatinib exports, indicating a relatively concentrated supply base.
Across all 127 tracked manufacturers, the total Lenvatinib export value stands at $2.1M from 863 shipments. The market average shipment value is $2.5K. The single largest buyer relationship in terms of trade value is M/S. RANBAXY FARMACE, receiving $349.3K worth of product.
The combined buyer network spans 18 named purchasing companies, including M/S. RANBAXY FARMACE, M/S. SUN FARMACEUTIC, M/S., SUN FARMACEUTICA DO , LEK PHARMACEUTICALS D.D. and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Lenvatinib exporter from India, with a market share of 35.0% and a total export value of $746.3K across 5 shipments. Their average shipment value of $149.3K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M/S. RANBAXY FARMACE — $349.3K across 2 shipments (46.8% of this supplier's total exports)
• M/S. SUN FARMACEUTIC — $211.8K across 1 shipments (28.4% of this supplier's total exports)
• M/S. — $185.1K across 1 shipments (24.8% of this supplier's total exports)
• SUN FARMACEUTICA DO — $9 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $149.3K is 5943% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
2SANDOZ PRIVATE LIMITED
SANDOZ PRIVATE LIMITED is the second-largest Lenvatinib exporter from India, with a market share of 12.8% and a total export value of $272.8K across 41 shipments. Their average shipment value of $6.7K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. LEK PHARMACEUTICALS D.D. is the dominant customer, accounting for 92.9% of this supplier's tracked business. Top customers include:
• LEK PHARMACEUTICALS D.D. — $253.3K across 38 shipments (92.9% of this supplier's total exports)
• LEK PHARMACEUTICALS D.D. — $13.0K across 2 shipments (4.8% of this supplier's total exports)
• SANDOZ DO BRASIL IND — $3.2K across 0 shipments (1.2% of this supplier's total exports)
• URBAN KRAJNC — $1.7K across 0 shipments (0.6% of this supplier's total exports)
• LEK PHARMACEUTICALS D.D. — $1.6K across 0 shipments (0.6% of this supplier's total exports)
Key Insight: SANDOZ PRIVATE LIMITED's per-shipment value of $6.7K is 169% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
3PROSPERA LIFE SCIENCES PRIVATE LIMITED
PROSPERA LIFE SCIENCES PRIVATE LIMITED is the third-largest Lenvatinib exporter from India, with a market share of 4.8% and a total export value of $101.9K across 42 shipments. Their average shipment value of $2.4K is below the market average of $2.5K, reflecting a high-volume, competitive pricing strategy.
PROSPERA LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. STR INTERNATIONAL TRADING CO LTD is the dominant customer, accounting for 50.7% of this supplier's tracked business. Top customers include:
• STR INTERNATIONAL TRADING CO LTD — $51.7K across 21 shipments (50.7% of this supplier's total exports)
• STR INTERNATIONAL TRADING CO LTD — $32.5K across 13 shipments (31.8% of this supplier's total exports)
• MR. NORLADETH THAMMA — $9.1K across 4 shipments (8.9% of this supplier's total exports)
• AS PER INVOICE — $5.3K across 2 shipments (5.2% of this supplier's total exports)
• STR INTERNATIONAL TRADING CO LTD — $3.4K across 1 shipments (3.4% of this supplier's total exports)
Key Insight: PROSPERA LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (42 shipments) at a per-shipment value of $2.4K, indicating a broad distribution network with many smaller, regular orders.
4BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the fourth-largest Lenvatinib exporter from India, with a market share of 4.3% and a total export value of $91.3K across 21 shipments. Their average shipment value of $4.3K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED serves 5 named buyers in our database. TOROPH is the dominant customer, accounting for 54.2% of this supplier's tracked business. Top customers include:
• TOROPH — $49.5K across 11 shipments (54.2% of this supplier's total exports)
• AMINCORP — $36.3K across 8 shipments (39.8% of this supplier's total exports)
• ONLT ONCOPHARM U LTD — $4.8K across 1 shipments (5.3% of this supplier's total exports)
• IBSIPHSA — $661 across 0 shipments (0.7% of this supplier's total exports)
• TO , — $10 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED's per-shipment value of $4.3K is 76% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
5KARDI TRADING PRIVATE LIMITED
KARDI TRADING PRIVATE LIMITED is the fifth-largest Lenvatinib exporter from India, with a market share of 3.1% and a total export value of $65.1K across 6 shipments. Their average shipment value of $10.9K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
KARDI TRADING PRIVATE LIMITED serves 3 named buyers in our database. STR INTERNATIONAL TRADING CO LTD is the dominant customer, accounting for 98.0% of this supplier's tracked business. Top customers include:
• STR INTERNATIONAL TRADING CO LTD — $63.9K across 6 shipments (98.0% of this supplier's total exports)
• MARIA JULIANA GONCAL — $716 across 0 shipments (1.1% of this supplier's total exports)
• BENEDICT ARAUJO DOS — $565 across 0 shipments (0.9% of this supplier's total exports)
Key Insight: KARDI TRADING PRIVATE LIMITED's per-shipment value of $10.9K is 339% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
6GNH INDIA PHARMACEUTICALS LIMITED
GNH INDIA PHARMACEUTICALS LIMITED is the fifth-largest Lenvatinib exporter from India, with a market share of 1.9% and a total export value of $41.0K across 20 shipments. Their average shipment value of $2.1K is below the market average of $2.5K, reflecting a high-volume, competitive pricing strategy.
GNH INDIA PHARMACEUTICALS LIMITED serves 2 named buyers in our database. TO THE ORDER, is the dominant customer, accounting for 96.7% of this supplier's tracked business. Top customers include:
• TO THE ORDER, — $39.7K across 19 shipments (96.7% of this supplier's total exports)
• BURG HOEBERSSTRAAT 2 — $1.3K across 1 shipments (3.3% of this supplier's total exports)
Key Insight: GNH INDIA PHARMACEUTICALS LIMITED operates with high shipment frequency (20 shipments) at a per-shipment value of $2.1K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Lenvatinib Flows
Once Lenvatinib leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and SANDOZ PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $2.1M. Brazil absorbs the largest share at 38.3% ($815.6K), followed by Slovenia (14.6%) and Thailand (6.8%).
In Brazil — the top destination — named importers include `TO THE ORDER OF. In Slovenia, key buyers are LEK PHARMACEUTICALS D D, LEK PHARMACEUTICALS D.D..
This geographic spread reflects Lenvatinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Lenvatinib Go? Top Importing Countries & Their Buyers
Trade flow of Lenvatinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil ranks as the first-largest destination for Lenvatinib imports from India, with a total trade value of $815.6K across 6 shipments — representing a 38.3% share of all Lenvatinib exports. The average shipment value of $135.9K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lenvatinib importers in Brazil: `TO THE ORDER OF is the largest buyer, accounting for 2.8% ($22.6K) of this market's total imports.
• `TO THE ORDER OF — $22.6K (2.8% of Brazil's total)
Key Insight: Brazil's per-shipment average of $135.9K (5405% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Lenvatinib imports from India.
2Slovenia
Slovenia ranks as the second-largest destination for Lenvatinib imports from India, with a total trade value of $311.6K across 31 shipments — representing a 14.6% share of all Lenvatinib exports. The average shipment value of $10.1K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Lenvatinib importers in Slovenia: LEK PHARMACEUTICALS D D is the largest buyer, accounting for 81.3% ($253.3K) of this market's total imports.
• LEK PHARMACEUTICALS D D — $253.3K (81.3% of Slovenia's total)
• LEK PHARMACEUTICALS D.D. — $51.5K (16.5% of Slovenia's total)
Key Insight: Slovenia's per-shipment average of $10.1K (307% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Slovenia is a key market for Lenvatinib imports from India.
3Thailand
Thailand ranks as the third-largest destination for Lenvatinib imports from India, with a total trade value of $145.2K across 27 shipments — representing a 6.8% share of all Lenvatinib exports. The average shipment value of $5.4K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Lenvatinib importers in Thailand: STR INTERNATIONAL TRADING CO., LTD is the largest buyer, accounting for 44.0% ($63.9K) of this market's total imports.
• STR INTERNATIONAL TRADING CO., LTD — $63.9K (44.0% of Thailand's total)
• STR INTERNATIONAL TRADING CO LTD. — $51.7K (35.6% of Thailand's total)
• STR INTERNATIONAL TRADING CO LTD — $38.9K (26.8% of Thailand's total)
Key Insight: Thailand's per-shipment average of $5.4K (118% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Lenvatinib imports from India.
4United Arab Emirates
United Arab Emirates ranks as the fourth-largest destination for Lenvatinib imports from India, with a total trade value of $132.0K across 11 shipments — representing a 6.2% share of all Lenvatinib exports. The average shipment value of $12.0K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lenvatinib importers in United Arab Emirates: TO THE IMPORT MANAGER is the largest buyer, accounting for 33.4% ($44.1K) of this market's total imports.
• TO THE IMPORT MANAGER — $44.1K (33.4% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $12.0K (386% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Lenvatinib imports from India.
5Singapore
Singapore ranks as the fifth-largest destination for Lenvatinib imports from India, with a total trade value of $85.0K across 23 shipments — representing a 4.0% share of all Lenvatinib exports. The average shipment value of $3.7K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Lenvatinib importers in Singapore: RADEEP SERVICES is the largest buyer, accounting for 31.4% ($26.7K) of this market's total imports.
• RADEEP SERVICES — $26.7K (31.4% of Singapore's total)
• FREIGHT LINKS EXPRESS PTE LTD — $19.4K (22.9% of Singapore's total)
Key Insight: Singapore's per-shipment average of $3.7K (50% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Singapore is a key market for Lenvatinib imports from India.
People Also Ask — Lenvatinib Supplier & Trade Network
Who are the top suppliers of Lenvatinib from India?+
Which companies buy Lenvatinib from Indian manufacturers?+
Where does Lenvatinib exported from India go?+
What is the market share of the top Lenvatinib supplier from India?+
What is the average shipment value for Lenvatinib exports from India?+
Is Lenvatinib manufactured in India and exported globally?+
Which country imports the most Lenvatinib from India?+
Who are the buyers of Lenvatinib in Slovenia?+
How concentrated is the Lenvatinib supplier market in India?+
How do I find verified buyers for Lenvatinib in specific countries?+
Lenvatinib Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Lenvatinib exporter with a 35.0% market share and $746.3K in total exports — making it the single most important sourcing entity in this market.
- 2The top 127 suppliers collectively account for 61.9% of all tracked Lenvatinib exports, with a combined trade value of $2.1M.
- 3Brazil is the largest destination market, absorbing 38.3% of India's Lenvatinib exports ($815.6K). Slovenia (14.6%) and Thailand (6.8%) follow.
- 4With 863 total shipments averaging $2.5K each, the Lenvatinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include M/S. RANBAXY FARMACE, M/S. SUN FARMACEUTIC, LEK PHARMACEUTICALS D.D., LEK PHARMACEUTICALS D.D. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 74 countries
Network value: $2.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lenvatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lenvatinib.
- 2.Flow Mapping: 127 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 863 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 74 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
863 Verified Shipments
127 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists